Antares Pharma (ATRS) News Today → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free ATRS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative January 24, 2024 | morningstar.comAntares Vision SpA AVDecember 7, 2023 | lse.co.ukAntares Vision Share Price (AV.MI)October 19, 2023 | markets.businessinsider.comAprea Therapeutics’ Promising Clinical Data and Distinctive Drug Profile: An Analysis of Jason McCarthy’s Buy RatingSeptember 3, 2023 | thestreet.comAntares Reaches New 52-Week High (AIS)August 2, 2023 | investing.comAntares Vision SpA (ANV)April 27, 2023 | marketwatch.comCOP Syringes Market Competitive Situation By 2030April 6, 2023 | marketwatch.comPharma Track and Trace Solutions Market Trends By 2031March 28, 2023 | marketwatch.comTransdermal Patch Drug Delivery System Market Size, Share, Demand, Opportunity, Outlook, Trends, Revenue, and Future Growth 2027March 27, 2023 | marketwatch.comDrug Transport Technology Market Top Players By 2031March 25, 2023 | marketwatch.comDrug Delivery Technology Market 2023 Size and Forecast to 2030March 4, 2023 | marketwatch.comPharma Track and Trace Solutions Market Forecast 2023 To 2029 Size, Global Predictive AnalyticsFebruary 17, 2023 | yahoo.comGlobal Genitourinary Drugs Market Report 2022 to 2027: Featuring Allergan, Antares Pharma, Bayer and Novartis Among OthersJanuary 4, 2023 | marketwatch.comPharma Track and Trace Solutions Market : Analysis, Forecast, Size, New Trends and Insights, Update, COVID-19 ImpactDecember 16, 2022 | marketwatch.comPharma Track and Trace Solutions Market 2022 : Incredible Possibilities, Growth Analysis and Forecast To 2028December 1, 2022 | marketwatch.comDrug Delivery Technology Market Global Demand, Opportunities, Trends, Analysis and Forecast to 2030September 14, 2022 | yahoo.comPharmaceutical Drug Delivery Global Market Report 2022August 20, 2022 | marketwatch.comPharma Track and Trace Solutions Market Report Detailed Market Analysis and Forecasts 2022 To 2028 | 112 Pages ReportJune 8, 2022 | msn.comLooking Into Antares Pharma's Return On Invested CapitalMay 24, 2022 | marketbeat.comTrading was temporarily halted for "ATRS" at 07:05 PM with a stated reason of "News pending."May 19, 2022 | seekingalpha.comHalozyme: Antares Pharma Bolsters Growth ProspectsMay 6, 2022 | finance.yahoo.comMiMedx Group and Inozyme Stock See Action From Activist InvestorsApril 26, 2022 | finance.yahoo.comHALOZYME COMMENCES TENDER OFFER FOR ALL OUTSTANDING SHARES OF COMMON STOCK OF ANTARES PHARMAApril 14, 2022 | benzinga.comLooking Into Antares Pharma Inc's Recent Short InterestApril 14, 2022 | finance.yahoo.comAntares Pharma (ATRS) Moves 49.2% Higher: Will This Strength Last?April 13, 2022 | finance.yahoo.comAntares Pharma to be acquired by Halozyme in $960M dealApril 13, 2022 | investorplace.comWhy Is Antares Pharma (ATRS) Stock Up Today?April 13, 2022 | morningstar.comAntares Pharma stock rockets after Halozyme buyout deal for a near-50% premiumApril 13, 2022 | fool.comWhy Antares Pharma Stock Is Bolting Higher TodayMarch 29, 2022 | stockhouse.comAntares Pharma Announces FDA Approval Of TLANDO(TM), an Oral Treatment for Testosterone Replacement TherapyMarch 29, 2022 | msn.comThe Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For AkebiaMarch 29, 2022 | seekingalpha.comAntares wins full FDA approval for testosterone replacement therapyMarch 29, 2022 | finance.yahoo.comAntares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement TherapyMarch 8, 2022 | benzinga.comAntares Pharma's Return On Capital Employed OverviewMarch 8, 2022 | seekingalpha.comAntares Pharma (ATRS) Investor Presentation - SlideshowMarch 7, 2022 | marketbeat.comZacks Investment Research Upgrades Antares Pharma (NASDAQ:ATRS) to HoldZacks Investment Research upgraded Antares Pharma from a "sell" rating to a "hold" rating in a research report on Monday.March 3, 2022 | apnews.comAntares Pharma: Q4 Earnings SnapshotMarch 3, 2022 | finance.yahoo.comAntares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating ResultsMarch 3, 2022 | finance.yahoo.comAntares Pharma (ATRS) Surpasses Q4 Earnings and Revenue EstimatesFebruary 28, 2022 | finance.yahoo.comSmileDirectClub (SDC) Reports Q4 Loss, Lags Revenue EstimatesFebruary 28, 2022 | finance.yahoo.comAntares Pharma to Present at the Cowen 42nd Annual Healthcare ConferenceFebruary 18, 2022 | finance.yahoo.comAntares Pharma (NASDAQ:ATRS) Could Easily Take On More DebtFebruary 15, 2022 | finance.yahoo.comHenry Schein (HSIC) Q4 Earnings and Revenues Beat EstimatesJanuary 13, 2022 | nasdaq.comHere's Why I Think Antares Pharma (NASDAQ:ATRS) Might Deserve Your Attention TodayJanuary 13, 2022 | finance.yahoo.comAntares Pharma, Inc.'s (NASDAQ:ATRS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?January 12, 2022 | finance.yahoo.comAntares Pharma Appoints Claude E. Richardson as Senior Vice President of Human ResourcesJanuary 11, 2022 | finance.yahoo.comAntares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis RescueDecember 17, 2021 | finance.yahoo.comMedMira strengthen its Board with New AppointmentDecember 16, 2021 | markets.businessinsider.comAssertio Shares Gain After Buying Antares' Rheumatoid Arthritis Treatment For $44MDecember 8, 2021 | finance.yahoo.comIf You Like EPS Growth Then Check Out Antares Pharma (NASDAQ:ATRS) Before It's Too LateNovember 8, 2021 | finance.yahoo.comLPCN: Antares Agreement & NASH Fast Track Change the Calculus Get Antares Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRS and its competitors with MarketBeat's FREE daily newsletter. Email Address The only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral. Stream the documentary for free by clicking here ATRS Media Mentions By Week ATRS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRS News Sentiment▼0.000.76▲Average Medical News Sentiment ATRS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRS Articles This Week▼00▲ATRS Articles Average Week Get Antares Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATRI News ANIK News OSUR News CERS News UTMD News ANGO News ARAY News CTSO News ICUI News AORT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss Ratings“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Antares Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
